ObsEva SA (OBSV): Price and Financial Metrics

ObsEva SA (OBSV): $0.10

0.02 (-15.52%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add OBSV to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#98 of 401

in industry

OBSV Price/Volume Stats

Current price $0.10 52-week high $2.14
Prev. close $0.12 52-week low $0.08
Day low $0.10 Volume 8,230,800
Day high $0.12 Avg. volume 8,942,389
50-day MA $0.17 Dividend yield N/A
200-day MA $0.46 Market Cap 7.94M

OBSV Stock Price Chart Interactive Chart >


ObsEva SA (OBSV) Company Bio


ObsEva SA, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women between the ages of 15 and 49 suffering from reproductive health and pregnancy. The company intends to develop treatments for treating endometriosis, uterine fibroids, and preterm labor. The company was founded in 2012 and is based in Switzerland.


OBSV Latest News Stream


Event/Time News Detail
Loading, please wait...

OBSV Latest Social Stream


Loading social stream, please wait...

View Full OBSV Social Stream

Latest OBSV News From Around the Web

Below are the latest news stories about OBSEVA SA that investors may wish to consider to help them evaluate OBSV as an investment opportunity.

ObsEva Announces Progress Towards its Plans to Consolidate Operations in Switzerland: Delisting of OBSV from The Nasdaq Stock Market effective March 23, 2023

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – March 15, 2023 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies for women’s health, today announced that it received a notification letter from The Nasdaq Stock Market LLC (“Nasdaq”) on March 14, 2023, advising the Company that its securities are scheduled for delisting from The Nasdaq Capital Market and will be suspended at the opening of U.

Yahoo | March 15, 2023

ObsEva Announces Update Towards its Strategic Reorganization to Consolidate Operations in Switzerland

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – March 13, 2023 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies for women’s health, today announced that Ernest Loumaye, MD, PhD, co-founder and member of the Board of Directors has been appointed as Interim Chairman following the resignation of Annette Clancy. It is expected that Dr. Loumaye will serve in this position until the 2023 Annual

Yahoo | March 13, 2023

10 Penny Stocks with Insider Buying

In this piece, we will take a look at ten penny stocks with insider buying. For more penny stocks, head on over to 5 Penny Stocks with Insider Buying. With the first quarter of 2023 coming to an end, the stock market continues to be in a topsy-turvy environment. 2023 was off to a strong […]

Yahoo | March 9, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

We're getting into the biggest pre-market stock movers traders will want to keep an eye on Wednesday with the latest news!

William White on InvestorPlace | March 8, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

We're starting off Friday morning with a breakdown of the biggest pre-market stock movers traders need to keep an eye on!

William White on InvestorPlace | March 3, 2023

Read More 'OBSV' Stories Here

OBSV Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year -96.63%
5-year -99.09%
YTD N/A
2023 0.00%
2022 -92.71%
2021 -4.33%
2020 -45.55%
2019 -69.83%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!